The latest announcement is out from AxoGen (AXGN).
Axogen, Inc. recently held its 2024 annual shareholders’ meeting, where a significant decision was made not to re-nominate Mr. Gregory Freitag for the board, leading to the acceleration of his stock benefits. Shareholders cast their votes on four key proposals, including the election of new directors, ratification of independent auditors, executive compensation, and an amendment to the incentive plan. While the first three proposals received approval, with nine directors elected and Deloitte & Touche LLP continuing as auditors, the proposal to amend the long-term incentive plan was rejected by the shareholders.
Find detailed analytics on AXGN stock on TipRanks’ Stock Analysis page.
